| mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
MS-275 |
GDSC1000 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
0.0036 |
0.9 |